Chems Every Week covers nootropics, peptides, neuropharmacology and related research. Each issue is built around one compound, with selected studies, a mechanism explained in ordinary language and links to original sources.
01 / Coverage
The regular format is a compound profile, research updates and a short reading list. Longer articles are published when a subject needs more space. Neuroscience provides context for coverage of learning, memory and cognition. Other subjects include supplements, experimental compounds and clinical trials.
02 / Occasional anecdotal reports
An issue may include an account from the editor or another contributor when it is relevant to the compound or topic. This is an optional section, not a standing feature in every edition.
Accounts are attributed and identified as anecdotal. The context, other changes and limitations are stated where known. A personal account is not presented as a clinical result, and no experiences are invented to fill an issue.
03 / Sources and corrections
Research summaries identify the studied population, comparison, outcome and time frame. Preclinical work and human studies are distinguished. Original sources are linked wherever available, and uncertainty is kept beside the claim.
Sources are checked before publication. Corrections are recorded on the affected article with the date and a description of the change.
04 / Editorial policy
This is an independent publication. Any relevant commercial relationship is disclosed alongside the material. Partner commissions support the newsletter without determining editorial conclusions.
Content is informational and educational. It is not medical advice or a recommendation to use a research compound.
05 / Correspondence
Send corrections, source material or relevant accounts to contact@chemseveryweek.com.